Fatal liver and lung alveolar echinococcosis with newly developed neurologic symptoms due to the brain involvement by Kvascevicius, Robertas et al.
Zurich Open Repository and
Archive
University of Zurich
Main Library
Strickhofstrasse 39
CH-8057 Zurich
www.zora.uzh.ch
Year: 2016
Fatal liver and lung alveolar echinococcosis with newly developed neurologic
symptoms due to the brain involvement
Kvascevicius, Robertas; Lapteva, Ona; Awar, Omar; Audronyte, Egle; Neverauskiene, Laura;
Kvasceviciene, Eleonora; Sokolovas, Vitalijus; Strupas, Kestutis; Marcinkute, Audrone; Deplazes, Peter;
Müllhaupt, Beat
Abstract: The fox tapeworm Echinococcus multilocularis causes human alveolar echinococcosis, com-
monly affecting the liver. However, in ￿1% of cases, systematic spread of the disease involves the brain
as well. A patient had a 6-year history of liver and lung alveolar echinococcosis that was considered not
suitable for surgery, and treatment with albendazole was introduced. After the appearance of neuro-
logic disturbances, an intracranial mass lesion was demonstrated by radiologic imaging. The lesion was
surgically removed, and histologic analysis revealed metacestode tissue of E. multilocularis. Despite the
surgical resection of the lesion, the patient died of progression of systemic alveolar echinococcosis. The
authors highly recommend implementing neurologic monitoring to the follow-up algorithm for patients
with systemically disseminated alveolar echinococcosis. When neurologic symptoms occur, radiologic
imaging of the brain should be obtained immediately. Surgery should be considered for all intracranial
echinococcal lesions, unless the lesion is located in the eloquent brain area.
DOI: 10.1055/s-0036-1592122
Posted at the Zurich Open Repository and Archive, University of Zurich
ZORA URL: http://doi.org/10.5167/uzh-126571
Published Version
 
 
Originally published at:
Kvascevicius, Robertas; Lapteva, Ona; Awar, Omar; Audronyte, Egle; Neverauskiene, Laura; Kvascevi-
ciene, Eleonora; Sokolovas, Vitalijus; Strupas, Kestutis; Marcinkute, Audrone; Deplazes, Peter; Müll-
haupt, Beat (2016). Fatal liver and lung alveolar echinococcosis with newly developed neurologic symp-
toms due to the brain involvement. The Surgery Journal, 02(03):e83-e88. DOI: 10.1055/s-0036-1592122
Fatal Liver and Lung Alveolar Echinococcosis with
Newly Developed Neurologic Symptoms due to
the Brain Involvement
Robertas Kvascevicius1 Ona Lapteva1 Omar Al Awar1 Egle Audronyte2 Laura Neverauskiene3
Eleonora Kvasceviciene4 Vitalijus Sokolovas5 Kestutis Strupas5 Audrone Marcinkute6
Peter Deplazes7 Beat Müllhaupt8
1Centre of Neurosurgery, Vilnius University Hospital Santariskiu
Klinikos, Vilnius, Lithuania
2Centre of Neurology, Vilnius University Hospital Santariskiu Klinikos,
Vilnius, Lithuania
3Department of Pathology, Republican Vilnius University Hospital,
Vilnius, Lithuania
4Department of Radiology, Republican Vilnius University Hospital,
Vilnius, Lithuania
5Centre of Abdominal Surgery, Vilnius University Hospital Santariskiu
Klinikos, Vilnius, Lithuania
6Hospital of Infectious Diseases and Tuberculosis, Afﬁliate of Vilnius
University Hospital Santariskiu Klinikos, Vilnius, Lithuania
7 Institute of Parasitology, University of Zürich, Zürich, Switzerland
8Swiss HBP Center, University Hospital of Zürich, Zürich, Switzerland
Surg J 2016;2:e83–e88.
Address for correspondence Ona Lapteva, MD, Centre of
Neurosurgery, Vilnius University Hospital Santariskiu Klinikos,
Santariskiu Street 2, 08661, Vilnius, Lithuania
(e-mail: ona.lapteva@msn.com).
Case Report
A 63-year-old woman residing in northern Lithuania was
admitted to the Department of Neurosurgery at Republican
Vilnius University Hospital with severe headache, progressive
left-sided hemiparesis, and seizures. These symptoms, along
with ataxia and left-sided facial nerve palsy, were present for
several weeks and gradually worsened. The patient was
diagnosed 6 years before with liver alveolar echinococcosis
(AE) stage IV P4N4M1 with transdiaphragmatic bilateral
pulmonary dissemination (►Figs. 1, 2).1 The case was con-
sidered nonsurgical, and treatment with albendazole 400 mg
twice a daywas initiated. This treatment resulted in elevation
of hepatic enzymes, and the dose was reduced to 200 mg per
day. The patient developed pruritus, headache, and cardiac
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Abstract The fox tapeworm Echinococcus multilocularis causes human alveolar echinococcosis,
commonly affecting the liver. However, in 1% of cases, systematic spread of the
disease involves the brain as well. A patient had a 6-year history of liver and lung alveolar
echinococcosis that was considered not suitable for surgery, and treatment with
albendazole was introduced. After the appearance of neurologic disturbances, an
intracranial mass lesion was demonstrated by radiologic imaging. The lesion was
surgically removed, and histologic analysis revealed metacestode tissue of E. multi-
locularis. Despite the surgical resection of the lesion, the patient died of progression of
systemic alveolar echinococcosis. The authors highly recommend implementing neu-
rologic monitoring to the follow-up algorithm for patients with systemically dissemi-
nated alveolar echinococcosis. When neurologic symptoms occur, radiologic imaging of
the brain should be obtained immediately. Surgery should be considered for all
intracranial echinococcal lesions, unless the lesion is located in the eloquent brain area.
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pain. At the same year prior to the admission for the brain AE
lesion treatment, the patient was treated for obstructive
jaundice at the Department of Abdominal Surgery at Vilnius
University Hospital Santariškių Klinikos. An endoscopic ret-
rograde cholangiography and papillotomy with stent inser-
tion were performed. By all measures, the patient had a
terminal and further progressing systematic disease.
Magnetic resonance imaging (MRI) of the brain demon-
strated an irregular, contrast-enhancing, 40  34  25-mm
nodular lesion in the postcentral gyrus surrounded by exten-
sive perifocal edema (►Fig. 3).
During surgery, a solid lesion of the right motor cortexwas
identiﬁed and totally removed. The lesion was white to gray,
multilocular, limited, and easily distinguishable from the
normal brain tissue (►Fig. 4).
The histopathologic examination of the resected lesion
revealed multiple cysts with periodic acid-Schiff-positive
cuticular layers surrounded by necrosis, heavy inﬁltration
of inﬂammatory cells, and granulomatous reaction charac-
terized by epithelioid cells and multinucleated giant cells.
These morphologic ﬁndings conﬁrmed the suspected diag-
nosis of AE (►Fig. 5).
Fig. 1 Abdominal computed tomography with contrast media. (Left) A mass with diffuse amorphous calciﬁcation in the right liver lobe. (Right)
The lesion with calciﬁed margins occupying the right liver lobe and involving the portal vein system.
Fig. 2 Thoracic computed tomography with contrast media. (Left) The calciﬁed lesions with lobulated contours in the right lobe of lungs. (Right)
The lesion in the left lobe of lungs.
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The patient had a full neurologic recovery postoperatively.
On the second postoperative day, she experienced abdominal
pain. Clinical and radiologic investigation (plain abdominal
X-ray, abdominal ultrasound) demonstrated no signs of peri-
tonitis or intestinal obstruction (ileus), but ascites was noted,
which increased progressively to produce respiration insufﬁ-
ciency. On the ﬁfth postoperative day, the patient died of
cardiopulmonary insufﬁciency.
Discussion
In Lithuania, AE caused by the fox tapeworm Echinococcus
multilocularis is of increasing public health concern, with the
highest incidences recorded in Europe, varying from 0.03 per
100,000 inhabitants in 2004 to 0.57 in 2009 and 0.74 in 2012.
AE primarily affects the liver but in a quarter of the cases in
Lithuania extrahepatic disseminations were observed, and in
35.4% of the cases, the survival was less than 1 year from
diagnosis due to late diagnosis at stage IV of the disease. For
the control of this zoonosis, timely diagnosis and treatment in
humans as well as the development of local control programs
present major challenges.
AE with resultant brain involvement is rare (1%).2–6 Brain
involvement generally presents with focal neurologic deﬁcit
and features of raised intracranial pressure.5 The symptoms of
raised intracranial pressure are headache, nausea, and vomit-
ing. Other neurologic disturbances may include aphasia,
dysarthria, seizures, hemiparesis, vision impairment, and
cranial nerves palsies.2,3,6–9
Cerebral lesions can be solitary and multifocal. In general,
they are supratentorial and distributed within the middle
cerebral artery.4,10 In cranial computed tomography andMRI,
Fig. 3 Brain magnetic resonance imaging. Axial view T2-weighted image (upper left) and coronal view T2-weighted image (bottom left) showing
the irregular hypo-/hyperintense nodular lesion in the right postcentral gyrus with an extensive perifocal edema. Coronal ﬂuid-attenuated
inversion recovery image (upper right) showing the nodular iso-/hypointense lesion with a massive perifocal edema in the right parietal lobe.
Coronal T1-weighted image with contrast enhancement (bottom right) showing the multilocular cystic lesion with a perifocal edema resembling a
bunch of grapes.
The Surgery Journal Vol. 2 No. 3/2016
Liver and Lung Alveolar Echinococcosis with Brain Involvement Kvascevicius et al. e85
they appear as solid, semisolid, or multilocular cystic lesions
resembling a bunch of grapes. Calciﬁcation and perifocal
edema are common. The lesions showcontrast enhancement.
Ringlike, heterogeneous, nodular, and cauliﬂower-like
enhancement patterns have been reported.3–6,8,10–12 It is
important to differentiate AE from cerebral malignancies
(metastasis, high-grade gliomas) and other infective cerebral
diseases like tuberculosis, bacterial abscess, fungal infection,
toxoplasmosis, cysticercosis, and cystic echinococcosis.4,6
Currently, there is no consensus on treatment of brain AE.
Radical resection is the treatment of choice, except for the cases
when a surgical approach may cause mortality or considerable
morbidity (i.e., when the lesion is located in eloquent brain
areas). The patients undergo chemotherapywith benzimidazole
derivates (albendazole, mebendazole) for 2 years after the
radical surgery. Albendazole is a ﬁrst-choice drug for the treat-
ment of cerebral AE, because it penetrates the blood–brain
barrier better than mebendazole. If resection was incomplete
or if the case is nonsurgical, long-termor even lifelong treatment
with albendazole is initiated.6,9,13,14 Gamma knife radiosurgery
may also be considered.15
We report our experience of surgical treatment of brain AE.
Although extremely rare (<1%), cerebral echinococcosis
should be considered as a differential diagnosis of intracranial
mass lesions. In general, clinicians must be well aware of the
echinococcosis problem and must carefully consider the clini-
cal (i.e., medical history of echinococcosis) and epidemiologic
details (i.e., direct contact with the deﬁnitive hosts, residence
in an Echinococcus-endemic region) when examining the
patient. The appropriate diagnostic tools help to establish
the correct diagnosis quickly. Speciﬁc medical therapy pre-
vents the progression and systemic spread of echinococcosis.
The AE lesion in the brain may have been a consequence of
metastatic spread of the disease from the primary lesion in the
liver, which could have happened during a time of inappropri-
ate medical control of the disease. Such a moment might have
occurred when the patient experienced adverse effects from
the medical treatment, which could have led to the patient
taking the drugs irregularly or in inadequate doses.
Another explanation may be that the multiple onco-
spheres’ invasion resulted in all three primary lesions in
the liver, lung, and brain, but for some reasons the brain
lesion became clinically evident the latest. Aoki et al reported
a case of a patient infected with at least two oncospheres that
developed into two small primary separate cysts in different
liver segments.16
Our patient had her ﬁrst brain MRI scan when neurologic
symptoms appeared and not at the time of diagnosis of the
disease, so the primary brain lesion/metastatic brain lesion
cannot be proved or denied.
If we presume that the brain lesion was a primary lesion
along with the liver and lung lesions, why then was it
clinically silent for more than 13 years? Is it possible that
liver echinococcosis progressed while the brain lesion was
Fig. 4 Postoperative computed tomography. This image shows the radical removal of the lesion.
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occult despite the poor drug penetration into the brain tissue
and fewer intracranial mass compensatorymechanisms? This
question could only be answered if neurologic and neuro-
radiologic investigations had been initiated at the time of
diagnosis of disseminated AE.
Difﬁculties in controlling the dangerous progression of AE
led to the death of the patient. At the beginning, the patient
was diagnosed as being in the terminal stage of the disease.
We believe that the asymptomatic period may have lasted for
many years. Multidisciplinary screening and follow-up along
with the albendazole therapyand palliative surgery increased
the survival for 7 years after the establishment of the
diagnosis.
Conclusions
The authors highly recommend introducing neurologic
screening into the treatment and follow-up algorithm for
the patients with disseminated AE even though no neurologic
disturbances are evident. This recommendation is especially
important when the patient has the disease for a long time or
does not get adequate treatment. When neurologic symp-
toms occur, brain MRI scan should be obtained immediately.
Surgery should be considered for all intracranial echinococ-
cocal lesions, unless the lesion is located in the eloquent brain
area. In summary, clinicians must be aware of this condition
to allow early diagnosis, facilitate referral, and ensure prompt
treatment. Proper medical treatment, regular long-term
multidisciplinary follow-up, and early surgical interventions
may improve the clinical outcome and survival.
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Fig. 5 (Upper left) The gross pathologic specimen of the lesion removed during surgery. (Upper right) The section shows periodic acid-Schiff
(PAS)-positive cuticle layer characteristic of Echinococcus multilocularis cysts (arrows). PAS stain. (Lower left) The cystic lesion with parasite
surrounded by necrotic tissue. Hematoxylin and eosin stain. (Lower right) The surrounding brain tissue inﬁltrated by lymphocytes, plasmocytes,
and multinucleated giant cells (arrow).
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